MedTrace Logo

Warrior CARE: Naturalistic Observation and Harm Reduction

NCT05386862 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-05-03

No results posted yet for this study

Summary

This study is looking at therapeutic potential of reducing Tetrahydrocannabinol (THC) levels in regular cannabis smokers using contingency management (CM) intervention in a U.S. veteran population with post-traumatic stress disorder (PTSD).

Conditions

  • Post Traumatic Stress Disorder
  • Cannabis Use
  • Suicide

Interventions

BEHAVIORAL

Reduce THC Use

Reducing THC concentrations and increasing CBD to reduce PTSD symptom severity

Sponsors & Collaborators

  • Wayne State University

    lead OTHER

Principal Investigators

  • Leslie Lundahl, PhD · Wayne State University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-13
Primary Completion
2024-01-25
Completion
2024-01-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05386862 on ClinicalTrials.gov